Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Futura’s Problems Mount As Eroxon Sales Disappoint
Sep 23 2025
•
By
Tom Gallen
FDA would get slightly more budget authority funding than requested under a House bill.
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Strategy
More from Business